Diploma PLC full-year results 2026: EPS jumps 45% as margins expand
Diploma delivered 45% adjusted EPS growth in FY26, supported by strong organic revenue, acquisitions and a 400 basis-point margin increase.
This article covers information on Diploma PLC.
LON:DPLMDiploma PLC has delivered a notably strong set of full-year numbers, with rapid organic growth, acquisitions and margin expansion combining to lift adjusted earnings per share by 45%.
The Diploma PLC full-year results announcement was released on 17 November 2026 and covers the financial year ended 30 September 2026. That distinction matters: the release date is in FY27, while the reported figures relate to FY26.
For investors following Diploma PLC, the standout feature is not just the rate of growth. The group also improved returns, generated substantial cash and ended the year with lower leverage.
Diploma's key FY26 figures
| Metric | FY26 | FY25 | Change |
|---|---|---|---|
| Revenue | £1,840.3 million | £1,524.5 million | 21% |
| Organic revenue growth | 15% | 11% | 4 percentage points |
| Adjusted operating profit | £487.1 million | £342.7 million | 42% |
| Adjusted operating margin | 26.5% | 22.5% | 400 basis points |
| Statutory operating profit | £390.0 million | £283.7 million | 37.5% calculated |
| Free cash flow | £323.3 million | £247.2 million | 30.8% calculated |
| Adjusted earnings per share | 255.6p | 176.0p | 45% |
| Basic earnings per share | 192.2p | 137.9p | 39.4% calculated |
| Full-year dividend per share | 65.4p | 62.3p | 5% |
| Leverage | 0.7 times | 0.8 times | Improved |
| ROATCE | 25.3% | 20.9% | 440 basis points calculated |
Calculations in the table use the figures reported by Diploma. For example, statutory operating profit growth is calculated from £390.0 million and £283.7 million.
ROATCE means return on adjusted trading capital employed. It is a measure of the operating return generated from the capital used within the business. The increase to 25.3% is significant because it suggests Diploma's growth was accompanied by stronger capital efficiency.
Organic growth did much of the heavy lifting
Organic revenue grew by 15%, meaning growth from the existing portfolio before the effect of acquisitions and currency movements. That was ahead of the 11% achieved in FY25.
Diploma attributed the performance to attractive end markets, deeper penetration of its existing geographic markets and product extensions. Peerless continued to perform strongly, while the rest of the portfolio delivered broad-based organic growth of around 10%.
This matters because acquisition-led groups can sometimes become overly reliant on buying growth. Diploma's figures show that the underlying businesses also expanded strongly during FY26.
Controls was the clear engine of growth. The division represented 61% of group revenue and delivered 25% organic growth, supported by markets including aerospace, defence, datacentres and energy. Windy City, Peerless, Clarendon and IS Group each recorded double-digit growth.
Performance elsewhere was more restrained.
| Sector | Share of group revenue | FY26 organic growth | Commentary |
|---|---|---|---|
| Controls | 61% | 25% | Strong growth across several attractive end markets |
| Seals | 26% | 4% | Improved sequentially in the second half |
| Life Sciences | 13% | 1% | Challenging second half and difficult healthcare markets |
North American Seals delivered high-single-digit organic growth, but International Seals remained challenging, although Diploma said performance continued to improve.
Life Sciences faced tough healthcare markets and short-term product lifecycle effects. Management expects the first half of FY27 to remain challenging, making this the most obvious weak point within the current portfolio.
Margin expansion amplified earnings growth
Adjusted operating profit increased by 42% to £487.1 million, considerably faster than the 21% increase in revenue.
That operational gearing helped the adjusted operating margin rise from 22.5% to 26.5%. A basis point is one-hundredth of a percentage point, so the reported 400 basis-point improvement equals four percentage points.
Diploma credited its value-add model and strong execution. Whatever label is applied, the numbers show that the group retained substantially more operating profit from each pound of revenue than it did in FY25.
Adjusted earnings per share increased by 45% to 255.6p, while basic earnings per share rose to 192.2p. Investors should note the distinction between adjusted and statutory measures, with Diploma using alternative performance measures to assess underlying performance.
Acquisitions remain central to the strategy
Diploma acquired 16 businesses from the beginning of FY26 through to the announcement date. These deals cost approximately £368 million and added £50 million of annualised operating profit at an average EBIT multiple of around seven times.
Fourteen deals completed during FY26 cost approximately £281 million and added £37 million of annualised operating profit. A further two FY27 acquisitions cost around £87 million and added £13 million.
Recent purchases included businesses serving women's health, industrial sealing, aerospace fasteners, US defence and aftermarket pump parts. CDM, a US interconnect business serving defence customers, and Elite Manufacturing Systems were among the notable additions.
Annualised operating profit describes the expected profit contribution over a full year. It should not be confused with the amount actually included in Diploma's FY26 results, particularly where acquisitions completed late in the period.
The combination of 0.7 times leverage, £323.3 million of free cash flow and what management described as significant balance-sheet headroom leaves Diploma with capacity to continue pursuing acquisitions. The group also reported a healthy and diverse pipeline, although the value and timing of future deals were not disclosed.
Cash flow and dividend progress
Free cash flow increased by £76.1 million to £323.3 million, based on the reported FY26 and FY25 figures. Free cash flow conversion declined from 105% to 94%, but remained high while profits expanded rapidly.
Leverage reduced from 0.8 times to 0.7 times despite Diploma's acquisition activity. That balance between deploying capital and maintaining a relatively modest debt position is an important part of the investment case.
The board recommended a final dividend of 46.3p per share, taking the full-year payment to 65.4p, up 5%. The final dividend remains subject to shareholder approval at the annual general meeting on 13 January 2027.
If approved, it will be paid on 29 January 2027 to shareholders on the register on 15 January. The shares are due to trade ex-dividend from 14 January.
FY27 guidance points to moderation, not contraction
Diploma expects another strong performance in FY27, ahead of its financial model, on a constant-currency basis.
Management's guidance is:
- Total revenue growth of 12%.
- Organic revenue growth of 6%.
- Acquisitions announced to date contributing 6% to reported revenue growth.
- An adjusted operating margin of 25.5%.
- Double-digit growth in the first quarter, followed by moderation from the second quarter as comparatives become tougher.
Both total and organic growth are expected to slow from FY26's exceptional levels. The guided operating margin is also one percentage point, or 100 basis points, below FY26's 26.5% result.
Management said the margin outlook reflects continued investment to support future growth and the effect of acquisitions. Future deals could increase the acquisition contribution beyond the currently guided 6%, but no additional acquisitions are included until announced.
What investors should watch next
The main positives are the 15% organic growth rate, substantial margin expansion, strong cash generation, lower leverage and disciplined acquisition returns. Controls also enters FY27 with good momentum in several end markets.
The risks are equally clear. FY27 organic growth guidance drops to 6%, the margin is expected to ease to 25.5%, and Life Sciences is likely to remain challenging during the first half. International Seals also needs to continue its recovery.
Diploma's FY26 performance sets a demanding comparison. The next test is whether the group can integrate its enlarged portfolio, preserve attractive returns and deliver its FY27 guidance while investing for longer-term growth.
Related
Keep reading
Investing
Applied Nutrition FY26 results: revenue jumps 50.9% but cash conversion falls
Applied Nutrition delivered rapid FY26 growth and maintained its FY27 outlook, but margins, working capital and cash conversion need watching.
JoshuaNovember 16, 2026
Investing
Could Japan’s Monetary Policy Trigger a U.S. Market Crash?
Japan’s monetary policy can influence markets far beyond Tokyo. Here is how yen-funded trades, foreign bond portfolios and funding stress could amplify volatility, and what long-term investors should monitor.
JoshuaNovember 16, 2026
Investing
Individual Stocks or Index Funds: What Matters Over the Long Term?
Holding one successful company for decades can produce an exceptional result. It can also leave your wealth dependent on a single business. Here is a practical framework for comparing individual stocks with diversified指数
JoshuaNovember 16, 2026
Tagged
Last updated
Category
InvestingLikes
Star Rating
No ratings yet
Comments
No comments yet - start the conversation.